Success Metrics

Completion Rate
0%(0/1)
Active Trials
3(75%)
Terminated
1(25%)

Phase Distribution

Ph phase_2
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Terminated(1)

Detailed Status

Recruiting3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting375%
terminated125%

Recent Activity

3 active trials
Showing 4 of 4
recruitingnot_applicable

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

NCT05780814
recruitingphase_2

Resilience Enhancement Following Sleep Treatment

NCT07298941
recruitingnot_applicable

Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD

NCT07069517
terminatednot_applicable

Blood Pressure, Heart Rate Variability & Sleep in Veterans With PTSD

NCT01920451

Clinical Trials (4)

Showing 4 of 4 trials
NCT05780814Not Applicable

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

Recruiting
NCT07298941Phase 2

Resilience Enhancement Following Sleep Treatment

Recruiting
NCT07069517Not Applicable

Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD

Recruiting
NCT01920451Not Applicable

Blood Pressure, Heart Rate Variability & Sleep in Veterans With PTSD

Terminated

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4